Literature DB >> 1632858

Genetic and environmental determinants of factor VII coagulant activity in ethnic groups at differing risk of coronary heart disease.

A Lane1, J K Cruickshank, J Mitchell, A Henderson, S Humphries, F Green.   

Abstract

It has been shown previously that individuals possessing the Gln353 allele of factor VII have significantly lower factor VIIc levels. In this population based study of Europeans, Afro-Caribbeans and Gujarati Indians, the Gln353 allele was associated with lower factor VIIc in all groups, carriers having factor VIIc levels 20-25% below the group mean. Although the Afro-Caribbeans had the lowest factor VIIc levels, the frequency of the Gln353 allele was not different from the European sample. However, in the Gujaratis, the frequency of the Gln353 allele was significantly higher than in the Europeans (0.25 compared to 0.09, P less than 0.001). Factor VIIc is known to be positively correlated with plasma triglyceride levels, although the Gujaratis, having the highest mean triglyceride levels, did not have the highest mean factor VIIc levels. On examination of the relationship between triglycerides and factor VIIc in the Gujaratis there was a correlation (r = 0.23, P = 0.13) in individuals homozygous for the factor VII Arg353 allele, but no correlation (r = 0.001, P = 0.5) among Gln353 carriers. This striking difference suggests that the effect of triglycerides on factor VIIc is genotype specific and thus provides an example of gene-environment interaction. The high frequency of the Gln353 allele, with its associated lack of relationship between triglyceride and factor VIIc levels, may explain the lower than expected factor VIIc levels in the Gujaratis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1632858     DOI: 10.1016/0021-9150(92)90186-k

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  5 in total

1.  The effects of genotype and infant weight on adult plasma levels of fibrinogen, factor VII, and LDL cholesterol are additive.

Authors:  J A Henry; M Bolla; C Osmond; C Fall; D J Barker; S E Humphries
Journal:  J Med Genet       Date:  1997-07       Impact factor: 6.318

2.  Thrombotic vascular risk factors in inflammatory bowel disease.

Authors:  M Hudson; A Chitolie; R A Hutton; M S Smith; R E Pounder; A J Wakefield
Journal:  Gut       Date:  1996-05       Impact factor: 23.059

3.  The decanucleotide polymorphism in the factor VII promoter predicts factor VII plasma levels but not the risk of acute coronary syndromes.

Authors:  E Jimenez-Boj; J Schüttrumpf; E Forberg; H H Watzke; K Huber
Journal:  J Thromb Thrombolysis       Date:  2000-08       Impact factor: 2.300

4.  Effect of the factor VII R353Q missense mutation on plasma apolipoprotein B levels: impact of visceral obesity.

Authors:  Marie-Thérèse Berthier; Alain Houde; Jean Bergeron; Denis Prud'homme; Jean-Pierre Després; Marie-Claude Vohl
Journal:  J Hum Genet       Date:  2003-07-08       Impact factor: 3.172

5.  Population genetic and phylogenetic evidence for positive selection on regulatory mutations at the factor VII locus in humans.

Authors:  Matthew W Hahn; Matthew V Rockman; Nicole Soranzo; David B Goldstein; Gregory A Wray
Journal:  Genetics       Date:  2004-06       Impact factor: 4.562

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.